Front Page Demo Slide

HIPPA & HL7

1
2
3
4
LATEST NEWS:   With no deal on children's health plan, U.S. states scramble for Plan B - NEW YORK/WASHINGTON (Reuters) - For Nancy Minoui of Portland, Oregon, and Crystal Lett of Dublin, Ohio, Congress' failure to fund the Children's Health Insurance Program is not some distant tale of political wrangling.
LATEST NEWS:   Former Philippine President defends controversial dengue program - MANILA (Reuters) - Former Philippine President Benigno Aquino defended on Thursday his decision to implement a controversial immunization program using a new dengue vaccine in 2016, saying it was justified with millions of people at risk of being infected by the virus.
LATEST NEWS:   Investors call on Sanderson, Denny's, McDonald's to cut antibiotics - (Reuters) - An investor coalition that presses for corporate responsibility is calling on U.S. food companies McDonald's Corp, Denny's Corp and Sanderson Farms Inc to stop buying or producing meat raised with medically important antibiotics.
LATEST NEWS:   Treating bumps and humps: Dubai opens $10 million camel hospital - DUBAI (Reuters) - Pristine operating theaters and state-of-the-art medical equipment are featured in a new Dubai hospital that opened last week - exclusively for camels.
LATEST NEWS:   Ohio passes law barring abortion over Down syndrome diagnosis - CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.
LATEST NEWS:   Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval - (Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, the company said on Wednesday.
LATEST NEWS:   Bumper crop of new drugs fails to lift big pharma R&D returns - LONDON (Reuters) - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.
LATEST NEWS:   U.S. study sheds light on how Zika causes nerve disorder - CHICAGO (Reuters) - A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday.
LATEST NEWS:   Obamacare sign-ups rise but overall enrollment set to fall - NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.